Prescription Drugs 2 Go

Dr Reddy’s Laboratories has received the US Food and Drug Administration’s approval to launch the generic version of Sanofi-Aventis’ allergy drug Allegra, a spokesman said on Thursday. (Source: The Economic Times Healthcare and Biotech News)

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed – updated hourly from thousands of authoritative health and news sources.

Dr Reddy’s gets FDA nod for Allegra generic is a post from: Prescription Drugs

Actavis Group, the international generic pharmaceuticals company, today announced that it has received approval from the U.S. Food & Drug Administration to market Alprazolam orally disintegrating tablets. Distribution of the product will commence immediately. (Source: Pharmaceutical Online News)
Actavis Receives Approval of Alprazolam ODT in the U.S. is a post from: Prescription Drugs

FDA Committed to Addressing Growing National Overdose Problem
The U.S. Food and Drug Administration (FDA) recognizes the five-fold increase in unintentional drug overdose deaths noted by the Centers for Disease Control and Prevention between 1990 and 2006 as a serious public health concern. Much of this increase follows from increases in the deaths from the use of opioid drugs, which in 2006 accounted for more overdose deaths than heroin and cocaine combined. The agency is also concerned about misuse of benzodiazepines (e.g., Valium and Xanax), which accounted for 272,000 emergency department …

Updated Date: Mar 15, 2010 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))
THERACODOPHEN-LOW-90 (Hydrocodone Bitartrate And Acetaminophen) Tablet [Physician Therapeutics LLC] is a post from: Prescription Drugs

In this study, we prepared six nanometer-sized prodrugs (nanoprodrugs) of NSAIDs, ibuprofen, indomethacin, and naproxen through the spontaneous emulsification mechanism using monomeric and dimeric derivatives of the NSAIDs. We evaluated their effect on the proliferation of U87-MG glioma cells by cell counting, WST-1 cell proliferation reagent, and propidium iodide incorporation. The two ibuprofen nanoprodrugs inhibited the cell growth more potently than the indomethacin nanoprodrugs, whereas the naproxen nanoprodrugs did not show any significant effect. Remarkably, ibuprofen did not show any effect at an equimolar concentration. Approximately, 4.4% of the ibuprofen …

For many mothers of newborns, lingering pain from the delivery can interfere with their first days with their infant. A recent review examined whether over-the-counter medications containing acetaminophen Tylenol for example provided adequate relief for such pain and concluded that they are effective. Bruising during the delivery or interventions such as the use of forceps or an episiotomy can cause perineal pain… (Source: Health News from Medical News Today)
Acetaminophen Alone Works Well For Postpartum Pain is a post from: Prescription Drugs

For many mothers of newborns, lingering pain from the delivery can interfere with their first days with their infant. A recent review examined whether over-the-counter medications containing acetaminophen Tylenol for example provided adequate relief for such pain and concluded that they are effective… (Source: Pain / Anesthetics News From Medical News Today)
Acetaminophen Alone Works Well For Postpartum Pain is a post from: Prescription Drugs

Zogenix, Inc. (”Zogenix”), a privately held pharmaceutical company, announced that it has initiated a pivotal Phase 3 clinical trial with ZX002, a novel, oral, controlled-release formulation of hydrocodone without acetaminophen. ZX002 is being developed for the treatment of moderate to severe pain in individuals who require around-the-clock opioid therapy for the control of pain. Hydrocodone is the most widely prescribed drug in the United States, but there are currently no products available with hydrocodone only, or with controlled-release formulations… (Source: Health News from Medical News Today)
Zogenix Initiates Pivotal Phase 3 …

Zogenix, Inc. (”Zogenix”), a privately held pharmaceutical company, announced that it has initiated a pivotal Phase 3 clinical trial with ZX002, a novel, oral, controlled-release formulation of hydrocodone without acetaminophen. ZX002 is being developed for the treatment of moderate to severe pain in individuals who require around-the-clock opioid therapy for the control of pain… (Source: Pain / Anesthetics News From Medical News Today)
Zogenix Initiates Pivotal Phase 3 Clinical Trial For Novel Formulation Of Oral Controlled-Release Hydrocodone is a post from: Prescription Drugs

Conclusions. Acyclovir administered at a dosage of 400 mg twice daily is unlikely to be a useful long‐term intervention to reduce HIV transmission. The lack of effect on HIV may be attributable to suboptimal adherence or treatment regimen. Clinical trial registration. Current Controlled Trials registration no.: ISRCTN35385041. (Source: The Journal of Infectious Diseases Latest Issue)
Long‐Term Impact of Acyclovir Suppressive Therapy on Genital and Plasma HIV RNA in Tanzanian Women: A Randomized Controlled Trial is a post from: Prescription Drugs